Anti-MEGF8 monoclonal antibody

Pre-made anti-MEGF8 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MEGF8/MEGF8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1165-Ab-1/ GM-Tg-hg-IP1165-Ab-2Anti-Human MEGF8 monoclonal antibodyHuman
GM-Tg-rg-IP1165-Ab-1/ GM-Tg-rg-IP1165-Ab-2Anti-Rat MEGF8 monoclonal antibodyRat
GM-Tg-mg-IP1165-Ab-1/ GM-Tg-mg-IP1165-Ab-2Anti-Mouse MEGF8 monoclonal antibodyMouse
GM-Tg-cynog-IP1165-Ab-1/ GM-Tg-cynog-IP1165-Ab-2Anti-Cynomolgus/ Rhesus macaque MEGF8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1165-Ab-1/ GM-Tg-felg-IP1165-Ab-2Anti-Feline MEGF8 monoclonal antibodyFeline
GM-Tg-cang-IP1165-Ab-1/ GM-Tg-cang-IP1165-Ab-2Anti-Canine MEGF8 monoclonal antibodyCanine
GM-Tg-bovg-IP1165-Ab-1/ GM-Tg-bovg-IP1165-Ab-2Anti-Bovine MEGF8 monoclonal antibodyBovine
GM-Tg-equg-IP1165-Ab-1/ GM-Tg-equg-IP1165-Ab-2Anti-Equine MEGF8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1165-Ab-1/ GM-Tg-hg-IP1165-Ab-2; GM-Tg-rg-IP1165-Ab-1/ GM-Tg-rg-IP1165-Ab-2;
GM-Tg-mg-IP1165-Ab-1/ GM-Tg-mg-IP1165-Ab-2; GM-Tg-cynog-IP1165-Ab-1/ GM-Tg-cynog-IP1165-Ab-2;
GM-Tg-felg-IP1165-Ab-1/ GM-Tg-felg-IP1165-Ab-2; GM-Tg-cang-IP1165-Ab-1/ GM-Tg-cang-IP1165-Ab-2;
GM-Tg-bovg-IP1165-Ab-1/ GM-Tg-bovg-IP1165-Ab-2; GM-Tg-equg-IP1165-Ab-1/ GM-Tg-equg-IP1165-Ab-2
Products NameAnti-MEGF8 monoclonal antibody
Formatmab
Target NameMEGF8
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MEGF8 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1165-Ag-1Recombinant multi-species MEGF8/ C19orf49/ CRPT2 protein


    Target information

    Target IDGM-IP1165
    Target NameMEGF8
    Gene ID1954,269878,114029,709352,484474,101085511,615688,100146203
    Gene Symbol and Synonymsb2b1702.2Clo,b2b1702Clo,b2b288Clo,C19orf49,CRPT2,EGFL4,m687Ddg,MEGF8,mKIAA0817,SBP1
    Uniprot AccessionQ7Z7M0,Q9QYP0
    Uniprot Entry NameMEGF8_HUMAN,MEGF8_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000105429
    Target ClassificationN/A

    The target: MEGF8, gene name: MEGF8, also named as C19orf49, CRPT2, EGFL4, SBP1. The protein encoded by this gene is a single-pass type I membrane protein of unknown function that contains several EGF-like domains, Kelch repeats, and PSI domains. Defects in this gene are a cause of Carpenter syndrome 2. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.